NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
36000-324-02 | 36000-324 | HUMAN PRESCRIPTION DRUG | Labetalol Hydrochloride | Labetalol Hydrochloride | INJECTION, SOLUTION | INTRAVENOUS | 20210126 | N/A | ANDA | ANDA076051 | Baxter Healthcare Corporation | LABETALOL HYDROCHLORIDE | 5 mg/mL | 1 VIAL in 1 CARTON (36000-324-02) / 40 mL in 1 VIAL (36000-324-01) |
36000-322-02 | 36000-322 | HUMAN PRESCRIPTION DRUG | Labetalol Hydrochloride | Labetalol Hydrochloride | INJECTION, SOLUTION | INTRAVENOUS | 20210126 | N/A | ANDA | ANDA076051 | Baxter Healthcare Corporation | LABETALOL HYDROCHLORIDE | 5 mg/mL | 1 VIAL in 1 CARTON (36000-322-02) / 20 mL in 1 VIAL (36000-322-01) |
36000-320-10 | 36000-320 | HUMAN PRESCRIPTION DRUG | Labetalol Hydrochloride | Labetalol Hydrochloride | INJECTION, SOLUTION | INTRAVENOUS | 20210126 | N/A | ANDA | ANDA076051 | Baxter Healthcare Corporation | LABETALOL HYDROCHLORIDE | 5 mg/mL | 10 VIAL in 1 CARTON (36000-320-10) / 4 mL in 1 VIAL (36000-320-01) |